Han CL, Qu CZ. Cardiovascular risk and safety evaluation of a dual peroxisome proliferator-activated receptor-alpha/gamma agonist, aleglitazar, in type 2 diabetes patients: A meta-analysis. J Cardiovasc Pharmacol 2020 Jan 9. doi: 10.1097/FJC.0000000000000796.
PMID: 31929323